0001144204-13-029581.txt : 20130515 0001144204-13-029581.hdr.sgml : 20130515 20130515163807 ACCESSION NUMBER: 0001144204-13-029581 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130331 FILED AS OF DATE: 20130515 DATE AS OF CHANGE: 20130515 EFFECTIVENESS DATE: 20130515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Knoll Capital Management, LP CENTRAL INDEX KEY: 0001325083 IRS NUMBER: 133476926 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-11424 FILM NUMBER: 13847783 BUSINESS ADDRESS: STREET 1: 666 FIFTH AVENUE STREET 2: 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10103 BUSINESS PHONE: 212-808-7474 MAIL ADDRESS: STREET 1: 666 FIFTH AVENUE STREET 2: 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10103 13F-HR 1 v345102_13f.txt 13F-HR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13 F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2013 Check here if Amendment [ ]; Amendment Number: This Amendment (check one only): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Knoll Capital Management, L.P. Address: 5 East 44th Street New York, NY 10011 Form 13F File Number: 28-11424 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Fred Knoll Name: President Phone: 212-479-6440 Signature, Place and Date of Signing: /s/ Fred Knoll New York, NY May 14, 2013 -------------------- ------------- ----------------- [Signature] [City, State] [Date] Report Type (Check only one): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. NONE FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form 13F Information Table Entry Total: 10 Form 13F Information Table Value Total: $137,184 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F INFORMATION TABLE ------------------------------------------------------------------------------------------------------------------------------------ COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 ------------------------------------------------------------------------------------------------------------------------------------ VOTING AUTHORITY ----------------------------- ISSUER NAME CLASS TITLE CUSIP VALUE SHRS OR PRN SH/ PUT/ INVESTMENT OTHER SOLE SHARED NONE (x$1000) AMT PRN CALL DISCRETION MANAGERS ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ CNO Financial Group, Inc. Com 12621E103 3,395 296,470 SH SOLE NONE 296,470 - - ------------------------------------------------------------------------------------------------------------------------------------ Medivation, Inc. Com 58501N101 118,027 2,524,101 SH SOLE NONE 2,574,101 - - ------------------------------------------------------------------------------------------------------------------------------------ Sequenom Inc. Com New 817337405 3,852 928,100 SH SOLE NONE 928,100 - - ------------------------------------------------------------------------------------------------------------------------------------ Dendreon Corp. Com 24823Q107 1,224 258,200 SH SOLE NONE 258,200 - - ------------------------------------------------------------------------------------------------------------------------------------ Achillion Pharmaceuticals Inc. Com 00448Q201 875 100,000 SH SOLE NONE 100,000 - - ------------------------------------------------------------------------------------------------------------------------------------ Echo Therapeutics Inc. Com 27876L107 351 444,445 SH SOLE NONE 444,445 - - ------------------------------------------------------------------------------------------------------------------------------------ Ampio Pharmaceuticals Inc. Com 03209T109 4,592 1,004,776 SH SOLE NONE 1,004,776 - - ------------------------------------------------------------------------------------------------------------------------------------ Vivus Inc. Call 928551900 1,470 5,000 SH Call SOLE NONE 5,000 ------------------------------------------------------------------------------------------------------------------------------------ Genworth Financial Inc. Com Cl A 37247D106 3,200 320,000 SH SOLE NONE 320,000 - - ------------------------------------------------------------------------------------------------------------------------------------ Celgene Corp. Com 151020112 198 27,825 SH SOLE NONE 27,825 - - ------------------------------------------------------------------------------------------------------------------------------------